載入中
NASDAQHealthcareMedical - Specialties
最新資料
US$2.65
+US$0.06 · +2.32%
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
前收盤價
US$2.65
+US$0.06 · +2.32%
盤後
US$2.65
US$0.00 · 0.00%
10月12日 下午7:30 ET
盤中時間採用ET。市場資料可能有所延遲。
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
日內區間
目前US$2.65
52週區間
目前US$2.65
盤中時間採用ET。市場資料可能有所延遲。
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
日內區間
目前US$2.65
52週區間
目前US$2.65
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 5284.4萬 USD | 4810.2萬 USD | 5234.9萬 USD | 4451萬 USD | 4851.7萬 USD |
| 銷貨成本 | 3381.1萬 USD | 1874.2萬 USD | 1859萬 USD | 1537.9萬 USD | 1491.6萬 USD |
| 毛利 | 1903.3萬 USD | 2936萬 USD | 3375.9萬 USD | 2913.1萬 USD | 3360.1萬 USD |
| 研究與開發 | 337.3萬 USD | 508萬 USD | 484.4萬 USD | 454.4萬 USD | 432.1萬 USD |
| 銷售、一般及管理費用 | 3611.7萬 USD | 4312.5萬 USD | 4886.6萬 USD | 4814.9萬 USD | 4372.8萬 USD |
| 營業費用 | 2547.9萬 USD | 4820.5萬 USD | 5101.8萬 USD | 5269.3萬 USD | 4804.9萬 USD |
| 利息收入 | 110.8萬 USD | 160.6萬 USD | 92.1萬 USD | 15.7萬 USD | 1.1萬 USD |
| 利息支出 | 558.9萬 USD | 590.7萬 USD | 247.8萬 USD | 1.5萬 USD | 1萬 USD |
| 折舊和攤銷 | 65.5萬 USD | 59.9萬 USD | 69.2萬 USD | 89萬 USD | 90.3萬 USD |
| 營業利益 | −644.6萬 USD | −1884.5萬 USD | −1725.9萬 USD | −2356.2萬 USD | −1444.8萬 USD |
| 淨利 | −1121.1萬 USD | −2346.3萬 USD | −1871.3萬 USD | −2318.4萬 USD | −1517.2萬 USD |
公司資料更新於 2026年10月13日。
第三方分析師預期可能變動，並非 GoAI 建議。
平均目標
US$6.50
上漲空間 145.28%報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI334.13萬0.00%2.3兆 USD0.03%US$381.57-0.10%
Vanguard Extended Market ETFVXF121.89萬0.00%954億 USD0.05%US$233.52-0.63%
iShares Micro-Cap ETFIWC29.56萬0.02%13.17億 USD0.60%US$181.66-0.73%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM14萬0.12%1.16億 USD0.73%US$15.8484-0.58%
Dimensional - US Core Equity 2 ETFDFAC1846.670.00%885.59億 USD0.21%US$45.31-0.04%Vanguard Morningstar Total Stock Market ETFVTIVanguard Extended Market ETFVXFiShares Micro-Cap ETFIWCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMDimensional - US Core Equity 2 ETFDFACAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
